TY - JOUR T1 - Suicide and mental health during the COVID-19 pandemic in Japan JF - medRxiv DO - 10.1101/2020.10.06.20207530 SP - 2020.10.06.20207530 AU - Michiko Ueda AU - Robert Nordström AU - Tetsuya Matsubayashi Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/10/27/2020.10.06.20207530.abstract N2 - Background The coronavirus disease (COVID-19) pandemic is an unprecedented public health crisis, but its effect on suicide deaths is little understood.Method We analysed data from monthly suicide statistics between January 2017 and September 2020 and from online surveys on mental health filled out by the general population during the COVID-19 pandemic in Japan.Outcomes Compared to the last three years (2017-2019), the number of suicide deaths was lower than average during the initial phase of the pandemic but, starting in July 2020, exceeded the past trend. The source of the increase was mainly female suicides, whose numbers increased by more than 20% in August and September 2020. Suicides by young women (less than 40 years of age) experienced a 63.1% increase in August 2020 compared to the same month in the past three years. The number of suicides among students was also notably higher in August and September 2020 than the corresponding numbers of past years. Our survey data indicated the status of mental health among young women was worse than that of women above 40 years and also that young female workers were more likely than any other group to have experienced a job or income loss in recent months, suggesting adverse economic conditions surrounding some of these individuals.Interpretation Our results strongly indicate that continuous monitoring of mental health, particularly that of the most vulnerable populations identified in this study, and appropriate suicide prevention efforts are necessary during, and in the aftermath of, the COVID-19 pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was financially supported by JSPS Grants-in-Aid for Scientific Research Grant Number 20H01584. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The survey was approved by the Ethics Review Committee on Human Research of Waseda University (approval #: 2020-050) and Osaka School of International Public Policy, Osaka University.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data on suicide deaths are public data and thus can be shared. The individual survey data cannot be shared due to the sensitive nature of the study. ER -